Newtek Business Services Corp. to Report Third Quarter 2020 Financial Results on Wednesday, …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

BOCA RATON, Fla., Oct. 12, 2020 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (Nasdaq: NEWT), an internally managed business development company (“BDC”), today announced that it will report its third quarter 2020 financial results after the market closes on Wednesday, November 4, 2020. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive Officer, and Christopher Towers, Chief Accounting Officer, the following day, Thursday, November 5, 2020 at 8:30 am ET. The live conference call can be accessed by dialing (877) 303-6993 or (760) 666-3611.

A live webcast of the call and the corresponding presentation will be available in the ‘Events & Presentations’ section of the Investor Relations portion of Newtek’s website at http://investor.newtekbusinessservices.com/events-and-presentations. A replay of the webcast with the corresponding presentation

Read More

Mastercard Incorporated to Host Conference Call on Third-Quarter 2020 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

PURCHASE, N.Y.–(BUSINESS WIRE)–Oct 9, 2020–

On Wednesday, October 28, 2020, Mastercard Incorporated (NYSE: MA) will release its third-quarter 2020 financial results. The company will host a conference call to discuss these results at 9:00 a.m. Eastern Time.

The financial results will be posted on the company’s website at investor.mastercard.com. The company will issue an alert over a news wire when the earnings materials are publicly available, including a link to those documents.

Conference Call Details:
U.S. dial-in: (833) 714-0894
International dial-in (outside the U.S.): +1 778 560 2664
U.K. local dial-in: 02035478612
Conference ID: 2393503

A replay of the call will be available for 30 days and can be accessed below:
U.S. dial-in: (800) 585 8367
International dial-in (outside the U.S.): +1 416 621 4642
Conference ID: 2393503

A

Read More

Marchex and Edenbrook Capital Announce Results of Tender Offer for up to 10 Million Shares of Class B Common Stock of Marchex

SEATTLE–(BUSINESS WIRE)–Oct 8, 2020–

Marchex (NASDAQ: MCHX), a leading conversational analytics company that connects the voice of the customer to your business, announced today the results of joint and equal tender offer with Edenbrook Capital, LLC of up to 10 million shares of Marchex’s Class B common stock (the “ Shares ”) at $2.15 per share and conditioned on a minimum of 3 million shares being properly tendered (the “ Offer ”), which expired at 11:59 p.m., New York City time, on October 7, 2020.

Based on the count by Equiniti Trust Company, the depositary and paying agent for the Offer (the “ Depositary and Paying Agent ”), a total of 10,552,160 shares were properly tendered and not properly withdrawn at $2.15 per share, including 86,461 shares that were tendered through notices of guaranteed delivery.

Due to the tender offer being oversubscribed, Marchex and Edenbrook Capital will accept for payment

Read More

Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

NEW YORK & MIAMI–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in children 3 to <18 years of age with growth hormone deficiency (GHD), met its primary endpoint of improved treatment burden compared to GENOTROPIN® (somatropin) for injection administered once-daily.

Top-line results from the study demonstrated that treatment with somatrogon once-weekly improved the mean overall Life Interference total score after 12 weeks of treatment (8.63) compared to treatment with somatropin administered once-daily (24.13). The point estimate of the treatment difference was -15.49 (-19.71, -11.27 (95% CI); p<0.0001) in favor of somatrogon at the nominal 0.05 level. In addition, key secondary endpoints showed an overall benefit in treatment experience with the somatrogon once-weekly dosing regimen compared to the somatropin once-daily dosing regimen.

“We’re encouraged by findings to date that

Read More

DP DHL records “strong business development” in preliminary Q3 results

Deutsche Post DHL has managed to achieve an increase in earnings before interest and tax (ebit) during the third quarter of this year and recorded “strong business development” ahead of its shift in focus to ‘peak season’.

Chief executive Frank Appel said in the company’s preliminary third-quarter financial results: “We are now fully focused on preparing for an exceptionally strong Christmas business. For this, the safety of our employees and the quality of service for our customers remain our top priorities.”

Preliminary group ebit rose to €1.4bn in the third quarter of this year — a 45% year-on-year increase on the same period in 2019.

The group’s highest-performing division in the third quarter of this year was eCommerce Solutions, which posted a 1,150% year-on-year increase in ebit to €75m.

The company said this was due to an acceleration in “strong B2C volumes in its markets”.

The group’s Global Forwarding Freight

Read More